Näytetään 1 - 20 yhteensä 20 tuloksesta haulle '"эндотелиальная дисфункция"', hakuaika: 0,06s Tarkenna hakua
EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY
Klinicheskiy sluchay: primenenie alprostadila pri lechenii bol'noy s idiopaticheskoy (pervichnoy) legochnoy gipertenziey

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase

Combined use of statins and inhibitors of arginase l-norvaline for correcting endotoksin-inducing endotelial dysfunction
Динамика эндотелиальной дисфункции под воздействием нитратной нагрузки = Dynamics endothelial dysfunction nitrate under the influence of load

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
Dyslipidemia and endothelial function in women with metabolic syndrome associated with autoimmune thyroiditis

КОРРЕКЦИЯ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У БОЛЬНЫХ ХРОНИЧЕСКИМ ЛЕГОЧНЫМ СЕРДЦЕМ ИНГИБИТОРАМИ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА
Biological mechanisms of natural cytoprotection - a promising trend in the development of new medicines aimed at prevention and treatment of preeclampsia

THE CHRONIC PSYCHO-EMOTIONAL STRESS IS ACCOMPANIED BY ENDOTHELIAL DYSFUNCTION, PROMOTES VASCULAR REMODELING AND REDUCTION OF CEREBRAL PERFUSION
ENDOTHELIOPROTECTIVE AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR

Endothelial dysfunction in multiple sclerosis and management options using alpha-lipoic acid
FEATURES OF THE SYNTHESIS OF NITRIC OXIDE IN PATIENTS WITH BRONCHIONAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

THE RELATIONSHIP BETWEEN THE LEVEL OF SUPEROXIDDISMUTASE AND THE COEFFICIENT OF ENDOTHELIAL FUNCTION AT RESPIRATORY-CARDIAC COMORBIDITY
Prognostic significance of endothelial dysfunctional markers of the first stage of chronic kidney disease

Effect of combination antihypertensive therapy on the endothelial function in women with hypertension in perimenopause
Arginase II - a new target in the development of endothelium protectors

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity
CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Työkalut: RSS-syöte — Lähetä haku sähköpostilla — Tallenna haku